Dexterra reported third-quarter EPS of C$0.28, above the C$0.26 estimate. Revenue and adjusted EBITDA also increased year over year, according to the company’s results.
Dexterra Group Inc. (TSX: DXT) released its third-quarter 2026 results after markets closed on November 4. For the quarter ended September 30, the company earned C$0.28 per share, 7.7% more than analysts expected. That makes three estimate beats in the past four reported quarters. Visit the company’s stock page for more coverage and market data.
Recent earnings trend
Dexterra Group Inc
DXT.TO
DXT.TO
Dexterra Group Inc
WealthAwesomeMarket cap
$1.23B
P/E
27.3x
52W high
$19.88
52W low
$10.31
1W change
+6.67%
Beta
0.46
Analyst Price Targets
Based on analyst covering DXT · as of Nov 9, 2026
Wall Street analysts forecast DXT stock price to rise 8.2% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$21.28
+8.2% Upside
Previously C$20.00 on Nov 6, 2026
Current Price
C$19.66
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DXT's historical volatility
30-Day Vol
30.7%
Annualized
90-Day Vol
29.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$23.50
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$20.87 | C$18.77 – C$23.19 |
| 60 trading days | C$22.15 | C$19.07 – C$25.72 |
| 90 trading days | C$23.50 | C$19.57 – C$28.23 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 2 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 3 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-12-31 | 2027-03-02 | — | 0.2300 | — |
| 2026-09-30 | 2026-11-04 | 0.2800 | 0.2600 | +7.7% |
| 2026-06-30 | 2026-08-04 | 0.2000 | 0.1800 | +11.1% |
| 2026-03-31 | 2026-05-06 | 0.1900 | 0.1600 | +18.8% |
| 2025-12-31 | 2026-03-03 | 0.1200 | 0.1800 | -33.3% |
| 2025-09-30 | 2025-11-04 | 0.2100 | 0.2100 | +0.0% |
Investor takeaway: Dexterra beat the EPS estimate and grew revenue and adjusted EBITDA year over year. But revenue of C$291.2 million fell short of the C$305.52 million consensus listed in the earnings calendar. The EPS beat is only part of the picture. Investors should also consider the company’s share price and valuation. The stock closed at C$19.66, with a P/E ratio of about 27.3 and a reported profit margin of 4.01%.
C$0.28 EPS, versus C$0.26 expected
Dexterra’s EPS came in C$0.02 above expectations, a 7.7% surprise. The company also beat estimates by 11.1% in June and 18.8% in March, after missing by 33.3% in December. That’s a positive recent trend, but the revenue shortfall shows why investors should look beyond EPS.
Bull case
Dexterra grew revenue and adjusted EBITDA year over year and posted its third consecutive quarterly EPS beat. The company also reported C$38.3 million in quarterly free cash flow and declared a C$0.10-per-share dividend for the fourth quarter, according to the supplied results headline. Its workforce accommodation and commercial services businesses give investors exposure to contracted services and industrial activity. At the latest reported close, the share price was above its 50-day and 200-day moving averages. That strength doesn’t guarantee future returns.
Bear case
Revenue of C$291.2 million was below the earnings calendar consensus of C$305.52 million, despite year-over-year growth. Analysts also lowered their EPS estimate over the 30 days before the report, from C$0.27 to C$0.26. There were three downward revisions and none upward. Dexterra’s 4.01% profit margin leaves earnings exposed to higher costs or execution problems, and the shares were near the supplied 52-week high. Investors should weigh the EPS beat against revenue, margins, valuation and the company’s outlook.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
